{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:06:00Z","timestamp":1789067160539,"version":"build-2803163510"},"reference-count":29,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,8,7]]},"DOI":"10.2967\/jnumed.126.272271","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:10:28Z","timestamp":1789063828000},"page":"jnumed.126.272271","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative Thresholds on\n                    <sup>18<\/sup>\n                    F-DCFPyL PET for Determining Malignancy in Prostate Cancer with Pathologic Correlation"],"prefix":"10.2967","author":[{"given":"Liza","family":"Lindenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Ulaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Sonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Niknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Reza","family":"Berenji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpna","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Bergvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Cedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Carreon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynn","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximillian","family":"Lindenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Citrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Turkbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026091011102217000_jnumed.126.272271v1.1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2214\/AJR.19.22042","article-title":"Prospective evaluation of 18F-DCFPyL PET\/CT in detection of high-risk localized prostate cancer: comparison with mpMRI","volume":"215","author":"Gaur","year":"2020","journal-title":"AJR."},{"key":"2026091011102217000_jnumed.126.272271v1.2","doi-asserted-by":"crossref","first-page":"7056983","DOI":"10.1155\/2022\/7056983","article-title":"High SUVs have more robust repeatability in patients with metastatic prostate cancer: results from a prospective test-retest cohort imaged with 18F-DCFPyL","volume":"2022","author":"Werner","year":"2022","journal-title":"Mol Imaging."},{"key":"2026091011102217000_jnumed.126.272271v1.3","doi-asserted-by":"crossref","first-page":"110437","DOI":"10.1016\/j.clinimag.2025.110437","article-title":"CT-guided biopsy of 18F-piflufolastat radiotracer avid lesions in osseous metastatic prostate disease: initial experience, technical factors and biopsy yield","volume":"120","author":"Fenner","year":"2025","journal-title":"Clin Imaging."},{"key":"2026091011102217000_jnumed.126.272271v1.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263448"},{"key":"2026091011102217000_jnumed.126.272271v1.5","doi-asserted-by":"crossref","first-page":"e11824","DOI":"10.1002\/cjs.11824","article-title":"Variable selection in modelling clustered data via within-cluster resampling","volume":"53","author":"Ye","year":"2025","journal-title":"Can J Stat."},{"key":"2026091011102217000_jnumed.126.272271v1.6","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/88.4.1121"},{"key":"2026091011102217000_jnumed.126.272271v1.7","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.7150\/thno.58140","article-title":"Establishment and prospective validation of an SUVmax cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by 68Ga-PSMA PET\/CT: a real-world study","volume":"11","author":"Jiao","year":"2021","journal-title":"Theranostics."},{"key":"2026091011102217000_jnumed.126.272271v1.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.195172"},{"key":"2026091011102217000_jnumed.126.272271v1.9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12880-025-01557-9","article-title":"Which PSMA PET\/CT interpretation criteria most effectively diagnose prostate cancer? A retrospective cohort study","volume":"25","author":"Ma","year":"2025","journal-title":"BMC Med Imaging."},{"key":"2026091011102217000_jnumed.126.272271v1.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198119"},{"key":"2026091011102217000_jnumed.126.272271v1.11","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026091011102217000_jnumed.126.272271v1.12","first-page":"11","article-title":"Role of 18F-DCFPyL PET\/CT in patients with suspected prostate cancer","volume":"25","author":"Zhang","year":"2022","journal-title":"Hell J Nucl Med."},{"key":"2026091011102217000_jnumed.126.272271v1.13","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.1038\/s41598-024-65452-z","article-title":"Enhancing prostate cancer diagnosis and reducing unnecessary biopsies with [18F]DCFPyL PET\/CT imaging in PI-RADS 3\/4 patients","volume":"14","author":"Fu","year":"2024","journal-title":"Sci Rep."},{"key":"2026091011102217000_jnumed.126.272271v1.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264334"},{"key":"2026091011102217000_jnumed.126.272271v1.15","doi-asserted-by":"crossref","first-page":"800904","DOI":"10.3389\/fonc.2022.800904","article-title":"18F-DCFPyL PET\/CT in newly diagnosed prostate cancer: diagnostic value of intraprostatic PSMA uptake in risk classification of prostate cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol."},{"key":"2026091011102217000_jnumed.126.272271v1.16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41391-022-00534-5","article-title":"The differential diagnostic value of dual-phase 18F-DCFPyL PET\/CT in prostate carcinoma","volume":"25","author":"Tian","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2026091011102217000_jnumed.126.272271v1.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227520"},{"key":"2026091011102217000_jnumed.126.272271v1.18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13550-023-01033-x","article-title":"Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer","volume":"13","author":"Heilinger","year":"2023","journal-title":"EJNMMI Res."},{"key":"2026091011102217000_jnumed.126.272271v1.19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00256-024-04855-5","article-title":"Performance of PSMA-PET\/CT as verified by bone biopsy for diagnosing osseous metastases of prostate cancer","volume":"54","author":"Ou","year":"2025","journal-title":"Skeletal Radiol."},{"key":"2026091011102217000_jnumed.126.272271v1.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.179739"},{"key":"2026091011102217000_jnumed.126.272271v1.21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11307-019-01376-9","article-title":"Semiquantitative parameters in PSMA-targeted PET imaging with [18F]DCFPyL: intrapatient and interpatient variability of normal organ uptake","volume":"22","author":"Sahakyan","year":"2020","journal-title":"Mol Imaging Biol."},{"key":"2026091011102217000_jnumed.126.272271v1.22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11307-019-01375-w","article-title":"Semiquantitative parameters in PSMA-targeted PET imaging with [18F]DCFPyL: impact of tumor burden on normal organ uptake","volume":"22","author":"Werner","year":"2020","journal-title":"Mol Imaging Biol."},{"key":"2026091011102217000_jnumed.126.272271v1.23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2967\/jnumed.119.236075","article-title":"Repeatability of quantitative 18F-DCFPyL PET\/CT measurements in metastatic prostate cancer","volume":"61","author":"Jansen","year":"2020","journal-title":"J Nucl Med."},{"key":"2026091011102217000_jnumed.126.272271v1.24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bju.15710","article-title":"Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography\/computed tomography is associated with oncological outcomes in patients with prostate cancer","volume":"129","author":"Bodar","year":"2022","journal-title":"BJU Int."},{"key":"2026091011102217000_jnumed.126.272271v1.25","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1038\/s41598-024-53683-z","article-title":"Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET\/CT. A pilot study","volume":"14","author":"Garc\u00eda Vicente","year":"2024","journal-title":"Sci Rep."},{"key":"2026091011102217000_jnumed.126.272271v1.26","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s00259-024-06685-y","article-title":"Whole-body tumour burden on [18F]DCFPyL PET\/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics","volume":"51","author":"Garc\u00eda-Zoghby","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026091011102217000_jnumed.126.272271v1.27","first-page":"1357","article-title":"The role of castrate status and androgen deprivation therapy in PSMA-based 18F-DCFPyL PET\/CT imaging of metastatic prostate cancer patients","volume":"62","author":"Mena","year":"2021","journal-title":"J Nucl Med."},{"key":"2026091011102217000_jnumed.126.272271v1.28","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/diagnostics12092212","article-title":"PSA-stratified performance of [18F]DCFPyL PET\/CT in biochemically recurrent prostate cancer patients under androgen deprivation therapy","volume":"12","author":"Harsini","year":"2022","journal-title":"Diagnostics (Basel)."},{"key":"2026091011102217000_jnumed.126.272271v1.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2391-1"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:10:31Z","timestamp":1789063831000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":29,"alternative-id":["10.2967\/jnumed.126.272271"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272271","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}